Skip to main content
BGI Genomics Co., Ltd. logo

BGI Genomics Co., Ltd. — Investor Relations & Filings

Ticker · 300676 ISIN · CNE100003449 Shenzhen Stock Exchange Professional, scientific and technical activities
Filings indexed 1,656 across all filing types
Latest filing 2019-10-11 Major Shareholding Noti…
Country CN China
Listing Shenzhen Stock Exchange 300676

About BGI Genomics Co., Ltd.

https://www.bgi.com

BGI Genomics Co., Ltd. is a leading provider of integrated solutions for precision medicine, specializing in genomic sequencing and proteomic services. The company offers a comprehensive portfolio of clinical diagnostics and research services across various fields, including reproductive health, oncology, and infectious diseases. Key products include non-invasive prenatal testing, hereditary cancer screening, and pathogen identification tools. Leveraging proprietary DNBseq sequencing technology, BGI Genomics provides high-throughput, cost-effective genomic data analysis to healthcare providers, research institutions, and pharmaceutical companies worldwide. The organization focuses on advancing personalized medicine through large-scale genomic research and the development of innovative diagnostic applications, aiming to improve health outcomes by making advanced genetic insights accessible to a global population.

Recent filings

Filing Released Lang Actions
关于持股5%以上股东工商登记事项变更的公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement from Shenzhen BGI Genomics Co., Ltd. regarding changes in the business registration details of a shareholder holding more than 5% of the company's shares. It details changes in the partnership structure of the shareholder entity but explicitly states that there is no change in shareholding percentages or control. The document is short (1582 characters) and focuses on shareholder registration changes rather than financial results, management changes, or voting outcomes. This fits the definition of a Major Shareholding Notification (MRQ), as it reports changes related to a significant shareholder's registration details without altering shareholding levels.
2019-10-11 Chinese
关于控股股东一致行动人部分股权质押的公告
Share Issue/Capital Change Classification · 95% confidence The document is a public announcement regarding the pledge of shares by a controlling shareholder and its concerted parties. It details the number of shares pledged, the dates, the pledgee, and the risk warnings related to the share pledge. There is no financial statement, earnings data, or management discussion. The document is a regulatory announcement about share pledge activities, which fits the category of Share Issue/Capital Change (SHA) as it relates to changes in share capital status through pledging. The document length is short and it is not an announcement of a report publication or certification, so it is not RPA or RNS. Therefore, the best classification is SHA with high confidence.
2019-09-26 Chinese
关于向合格投资者公开发行公司债券获得中国证监会核准批复的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from Shenzhen BGI Co., Ltd. regarding the approval from the China Securities Regulatory Commission (CSRC) for the company to publicly issue corporate bonds to qualified investors. It details the approval specifics, issuance timeline, and compliance requirements. The content focuses on a capital raising activity through bond issuance, which aligns with updates on financing activities or capital structure changes. The document length is short (670 characters) and it is not a report itself but an announcement of regulatory approval for a financing event. Therefore, it fits best under the category 'Capital/Financing Update' (CAP).
2019-09-20 Chinese
关于持股5%以上股东参与认购基金份额结果暨减持计划实施完成公告
Major Shareholding Notification Classification · 95% confidence The document is an official announcement from Shenzhen BGI Genomics Co., Ltd. regarding the completion of a shareholding reduction plan by a shareholder holding more than 5% of shares. It details the shareholder's participation in subscribing to fund shares and the corresponding reduction in company shares. The text includes specific dates, share quantities, and compliance with relevant securities laws and stock exchange rules. The document is not a financial report, earnings release, or management discussion but rather a regulatory announcement about shareholding changes and fund subscription results. It fits the category of Major Shareholding Notification (MRQ) as it reports changes in significant share ownership levels and related transactions.
2019-09-18 Chinese
关于青岛华大基因健康医疗产业园投资进展暨全资子公司签订拍卖出让成交确认书的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Shenzhen BGI Genomics Co., Ltd. regarding the progress of an investment project and the signing of a confirmation letter for a land auction transaction by its wholly-owned subsidiary. It details the acquisition of land use rights, the investment amount, and the impact on the company. The document is relatively short (1600 characters) and focuses on a specific transaction and investment update rather than comprehensive financial data or a full report. It does not contain financial statements or detailed financial analysis. Therefore, it is best classified as a Capital/Financing Update (CAP) since it relates to investment and capital use progress.
2019-09-17 Chinese
2019年第四次临时股东大会之法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening, procedures, attendance, agenda, and voting results of Shenzhen BGI Genomics Co., Ltd.'s 2019 fourth extraordinary general meeting of shareholders. It details the legal compliance of the meeting's call, the qualifications of attendees, the agenda items, and the voting outcomes. The document does not contain financial statements or management discussion of financial results, nor is it a report publication announcement. It is a formal legal opinion related to a shareholders' meeting and the voting results. Therefore, the document best fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length (5950 characters) and content support this classification with high confidence.
2019-09-12 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.